MODULADORES DE CÉLULA INKT E MÉTODOS PARA O SEU USO

• 收藏
• 分享

专利权人:

LUDWIG INSTITUTE FOR CANCER RESEARCH LTD.

发明人:

申请号：

PT12798262

公开号：

PT2785683T

申请日:

2012.11.30

申请国别(地区):

PT

年份:

2020

代理人:

摘要：

Disclosed herein are &alpha；-galactosylceramide (&alpha；-GalCer) analogs and compositions thereof, methods of activating invariant Natural Killer T (iNKT) cells using said analogs, methods of treating diseases by activating iNKT cells using said analogs, and combination therapy of said analogs.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/